Two-year results from an ongoing international trial show that women with non-low-risk ductal carcinoma in situ (DCIS) report some poorer cosmetic and functional outcomes when they receive a tumour bed radiotherapy boost.

The findings should help oncologists discuss therapy options with their patients, say the authors, led by Professor Madeleine King, Australian cancer chair of cancer quality of life at the University of Sydney.